Akebia Therapeutics Inc (AKBA)
1.80
+0.01
(+0.56%)
USD |
NASDAQ |
Nov 18, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Price: 1.80 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2024 | 1.81 | 1.84 | 1.77 | 1.80 | 1.320M |
| Nov 15, 2024 | 1.85 | 1.87 | 1.76 | 1.79 | 2.515M |
| Nov 14, 2024 | 1.95 | 1.95 | 1.86 | 1.86 | 1.599M |
| Nov 13, 2024 | 1.95 | 1.983 | 1.89 | 1.92 | 2.123M |
| Nov 12, 2024 | 2.00 | 2.00 | 1.88 | 1.95 | 2.317M |
| Nov 11, 2024 | 1.92 | 2.02 | 1.90 | 1.99 | 2.895M |
| Nov 08, 2024 | 1.84 | 1.95 | 1.785 | 1.94 | 2.775M |
| Nov 07, 2024 | 1.74 | 1.91 | 1.67 | 1.865 | 4.755M |
| Nov 06, 2024 | 1.85 | 2.01 | 1.85 | 2.00 | 4.582M |
| Nov 05, 2024 | 1.85 | 1.86 | 1.78 | 1.86 | 2.510M |
| Nov 04, 2024 | 1.72 | 1.85 | 1.70 | 1.85 | 3.404M |
| Nov 01, 2024 | 1.70 | 1.75 | 1.68 | 1.69 | 2.075M |
| Oct 31, 2024 | 1.70 | 1.72 | 1.66 | 1.66 | 2.111M |
| Oct 30, 2024 | 1.70 | 1.74 | 1.63 | 1.70 | 2.703M |
| Oct 29, 2024 | 1.62 | 1.72 | 1.61 | 1.71 | 2.682M |
| Oct 28, 2024 | 1.585 | 1.660 | 1.585 | 1.63 | 2.464M |
| Oct 25, 2024 | 1.57 | 1.63 | 1.57 | 1.59 | 1.378M |
| Oct 24, 2024 | 1.60 | 1.69 | 1.56 | 1.58 | 2.218M |
| Oct 23, 2024 | 1.69 | 1.69 | 1.54 | 1.59 | 3.049M |
| Oct 22, 2024 | 1.39 | 1.65 | 1.39 | 1.64 | 6.097M |
| Oct 21, 2024 | 1.34 | 1.37 | 1.335 | 1.37 | 1.107M |
| Oct 18, 2024 | 1.32 | 1.34 | 1.30 | 1.34 | 978077.0 |
| Oct 17, 2024 | 1.33 | 1.34 | 1.312 | 1.33 | 800719.0 |
| Oct 16, 2024 | 1.32 | 1.33 | 1.30 | 1.33 | 768431.0 |
| Oct 15, 2024 | 1.31 | 1.34 | 1.31 | 1.31 | 1.054M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.25
Minimum
Nov 29 2022
13.58
Maximum
Jun 30 2020
2.871
Average
1.65
Median
Feb 02 2024
Price Benchmarks
| Corcept Therapeutics Inc | 52.62 |
| Eli Lilly and Co | 727.20 |
| Bioventus Inc | 11.25 |
| NovaBay Pharmaceuticals Inc | 0.6998 |
| Palatin Technologies Inc | 0.95 |
Price Related Metrics
| PS Ratio | 2.159 |
| Earnings Yield | -12.60% |
| Market Cap | 392.73M |